echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Guotan medicines have started to apply online!

    Guotan medicines have started to apply online!

    • Last Update: 2021-12-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 3, the results of the 2021 national drug negotiations were finally "officially announced.


    On December 8, the Shanghai Municipal Pharmaceutical Centralized Bidding and Purchasing Affairs Management Office issued the "Notice on Launching the 2021 National New Medical Insurance Catalogue Drug Linking Work", announcing the launch of the 2021 National New Medical Insurance List Drug Linking Work, and companies can log in Purchasing platform, to declare and list new drugs in the medical insurance catalogue and drugs in the medical insurance negotiation


    Newly added medicines in the medical insurance catalogue

    New medical insurance negotiation drugs

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.